v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net loss $ (17,749) $ (12,622)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 394 647
Amortization of debt (premium) and issuance costs 571 (381)
Amortization of right-of-use assets 598 39
Change in fair value of warrant liability 123 0
Change in fair value of convertible debt carried at fair value 0 835
Loss on disposal of fixed assets 338 0
Gain on debt extinguishment 0 (71)
Stock-based compensation expense 511 2,024
Issuance of convertible notes for legal services 275 384
Changes in operating assets and liabilities:    
Accounts receivable (611) 679
Prepaids and other current assets 4,524 (2,165)
Insurance receivable 100 308
Other non-current assets 502 495
Accounts payable (107) 1,480
Accrued liabilities (1,512) 379
Accrued interest 42 270
Other current liabilities 78 502
Contract liabilities (3,849) 900
Operating lease liability 29 (302)
Litigation settlement contingency 860 (308)
Other non-current liabilities 0 (515)
Net cash used in operating activities (14,883) (7,422)
Cash flows from investing activities:    
Purchases of property, machinery and equipment (228) 0
Proceeds from sale of property, machinery and equipment 12 0
Net cash used in investing activities (216) 0
Cash flows from financing activities:    
Proceeds from issuance of convertible notes and warrants 0 750
Payment of convertible notes (783) (672)
Payment of debt issuance costs 0 (78)
Proceeds from exercise of warrants 9,638 2,068
Payments for issuance costs related to exercise of warrants 0 (204)
Repurchase of Section 16 Officer shares for tax coverage exchange (18) (1)
Payment of deferred offering costs 0 (283)
Proceeds from issuance of common stock, pre-funded warrants and related warrants 107,030 5,000
Payments for issuance costs related to common stock, pre-funded warrants and related warrants (5,925) (598)
Net cash provided by financing activities 109,942 5,982
Increase in cash, cash equivalents and restricted cash 94,843 (1,440)
Cash, cash equivalents, and restricted cash, beginning of period 12,861 1,572
Cash, cash equivalents, and restricted cash, end of period $ 107,704 $ 132